SCHEMBL29566739

SCHEMBL29566739

O=S(=O)(Nc1nc(Oc2ccccc2)cc(-c2ccccc2)n1)c1cccc(F)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 2/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48
▸ MAPT P10636 5/20 0.44
▸ LOXL2 Q9Y4K0 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.41
▸ GPR39 O43194 1/20 0.40
▸ CYP1A2 P05177 5/20 0.39
▸ CYP2C9 P11712 5/20 0.39
▸ CYP2C19 P33261 5/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ NPSR1 Q6W5P4 3/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ ATM Q13315 2/20 0.39
▸ SDHB P21912 1/20 0.36
▸ PGR P06401 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ SCN9A Q15858 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310193 1.00 MAPK1 (0.48) MAPK1TDP1MAPTLOXL2ALDH1A1
SCHEMBL26812723 0.86 MAPT (0.50) MAPK1TDP1MAPTLOXL2ALDH1A1
SCHEMBL26812951 0.85 MAPK1 (0.47) MAPK1TDP1MAPTALDH1A1GPR39
SCHEMBL26812838 0.84 MAPK1 (0.46) MAPK1TDP1MAPTLOXL2ALDH1A1
SCHEMBL26813002 0.84 GPR39 (0.53) MAPK1TDP1MAPTALDH1A1GPR39
SCHEMBL26812825 0.82 TDP1 (0.51) MAPK1TDP1MAPTLOXL2ALDH1A1
SCHEMBL26806813 0.82 MAPT (0.61) MAPK1TDP1MAPTALDH1A1GPR39
SCHEMBL29566672 0.79 MAPK1 (0.39) MAPK1TDP1MAPTLOXL2ALDH1A1
SCHEMBL24310192 0.79 MAPK1 (0.39) MAPK1TDP1MAPTLOXL2ALDH1A1
SCHEMBL26812946 0.79 MAPK1 (0.47) MAPK1TDP1MAPTLOXL2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback